• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

VaxInnate

edit

Vaccine company seeking cures for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus. Based in Cranbury, NJ.

Milestones

edit

• 
  VaxInnate received $40M in Series C funding. (10/25/06)
  Posted 4/20/10 at 3:21am via thefreelibrary.com
• 
  VaxInnate received $30M in Series D funding. (6/14/09)
  Posted 6/16/09 at 8:28am via onbiovc.com

Videos

Screenshots

edit

Above: Home Page
Uploaded: 6/16/09

Sources

1. VaxInnate Secures $40 Million Series C Financing. (thefreelibrary.com) [edit]
2. VaxInnate Corp., Series D $30M (onbiovc.com) [edit]